BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27194890)

  • 21. Risk factors of thrombosis in abdominal veins.
    Dutta AK; Chacko A; George B; Joseph JA; Nair SC; Mathews V
    World J Gastroenterol; 2008 Jul; 14(28):4518-22. PubMed ID: 18680232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.
    Smalberg JH; Arends LR; Valla DC; Kiladjian JJ; Janssen HL; Leebeek FW
    Blood; 2012 Dec; 120(25):4921-8. PubMed ID: 23043069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
    Ventura P; Venturelli G; Marcacci M; Fiorini M; Marchini S; Cuoghi C; Pietrangelo A
    Thromb Res; 2016 May; 141():189-95. PubMed ID: 27065203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
    De Stefano V; Martinelli I
    Intern Emerg Med; 2010 Dec; 5(6):487-94. PubMed ID: 20532730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
    Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
    Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India.
    Bhattacharyya M; Makharia G; Kannan M; Ahmed RP; Gupta PK; Saxena R
    Am J Clin Pathol; 2004 Jun; 121(6):844-7. PubMed ID: 15198356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of splanchnic vein thrombosis.
    Elkrief L; Payancé A; Plessier A; d'Alteroche L; Ronot M; Paradis V; Valla D; Rautou PE
    JHEP Rep; 2023 Apr; 5(4):100667. PubMed ID: 36941824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK2V617F Mutation in Patient with Splanchnic Vein Thrombosis.
    Kumar N; Sharma S; Binota J; Ahluwalia J; Varma N; Naseem S; Chand I; Uppal V; Sinha SK
    Indian J Hematol Blood Transfus; 2020 Oct; 36(4):700-704. PubMed ID: 33100713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombophilic mutations and risk of retinal vein occlusion.
    Biancardi AL; Gadelha T; Borges WI; Vieira de Moraes H; Spector N
    Arq Bras Oftalmol; 2007; 70(6):971-4. PubMed ID: 18235909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis--a concise review.
    Shetty S; Ghosh K
    Thromb Res; 2011 Jun; 127(6):505-12. PubMed ID: 20961602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splanchnic vein thrombosis in the mediterranean area in children.
    El-Karaksy H; El-Raziky M
    Mediterr J Hematol Infect Dis; 2011; 3(1):e2011027. PubMed ID: 21869913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasminogen Activator Inhibitor-1 4G/5G Promoter Polymorphism in Adults with Splanchnic Vein Thrombosis: A Case-Control Study.
    Kollabathula A; Sharma S; Kumar N; Ahluwalia J; Das R; Varma N; Rana SS
    Indian J Hematol Blood Transfus; 2022 Jan; 38(1):169-172. PubMed ID: 35125725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portal Vein Thrombosis in Cirrhosis.
    Shukla A; Giri S
    J Clin Exp Hepatol; 2022; 12(3):965-979. PubMed ID: 35677518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Common Thrombophilia Factor Mutations in Central Retinal Vein Occlusion.
    Cevik MO; Cevik SG
    Beyoglu Eye J; 2019; 4(1):23-27. PubMed ID: 35187427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis.
    Li M; De Stefano V; Song T; Zhou X; Guo Z; Zhu J; Qi X
    Thromb Res; 2018 Jul; 167():96-103. PubMed ID: 29803161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombophilia testing in patients with venous thrombosis.
    Caprini JA; Goldshteyn S; Glase CJ; Hathaway K
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):550-5. PubMed ID: 16055356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.
    Mahmoud AE; Elias E; Beauchamp N; Wilde JT
    Gut; 1997 Jun; 40(6):798-800. PubMed ID: 9245936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
    Karaköse S; Oruç N; Zengin M; Akarca US; Ersöz G
    Turk J Gastroenterol; 2015 Jan; 26(1):42-8. PubMed ID: 25698270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prothrombotic disorders in abdominal vein thrombosis.
    Leebeek FW; Smalberg JH; Janssen HL
    Neth J Med; 2012 Nov; 70(9):400-5. PubMed ID: 23123534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.